Lazard Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Other funds holding MEDP
Lazard Asset Management's MEDP Position: Q3 2026 in Review
Lazard Asset Management increased its Medpace (MEDP) stake by 122% in Q3 2026, buying an estimated $11M and bringing the position to 34,081 shares worth $21.3M. The position accounts for 0.03% of the portfolio, ranked #331.
Lazard Asset Management first reported a position in MEDP in Q3 2019 and has held it in 28 quarters since. The position peaked at $30.6M in Q2 2024. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.
- Lazard Asset Management held 34,081 shares of Medpace worth $21.3M as of Q3 2026.
- Lazard Asset Management bought 18,699 Medpace shares in Q3 2026, an estimated $11M.
- Medpace made up 0.03% of Lazard Asset Management's portfolio in Q3 2026, its #331 holding.
- Lazard Asset Management first reported a position in Medpace in Q3 2019 and has held it in 28 quarters since.
- Lazard Asset Management's Medpace position peaked at $30.6M in Q2 2024.
- 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.
Based on Lazard Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.